Nicholas Dantzker, MD
Orthopaedic Surgery · Gallatin, TNNPI 1437545688
Payments from drug & device makers
What this record shows
This record is dominated by education: $24,000 of the $28,267 with a category attached, or 84.9%. Smith+Nephew accounts for 72.0% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2021 at $23,753 and has fallen 96.1% since, to $930 in 2025.
Across 86 payments — averaging $328.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$20K
- Arthrex$4K
- Alpha Orthopedic Systems$2K
- Stryker$1K
- Johnson & Johnson$164
- Zimmer Biomet$134
- plus $346 from 8 others
What the payments were for
- Travel & lodging$1,9497%
- Food & beverage$2,3188%
- Education$24,00085%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 4 | $20,340 |
| Arthrex | 33 | $3,953 |
| Alpha Orthopedic Systems | 12 | $2,149 |
| Stryker | 21 | $1,181 |
| Johnson & Johnson | 2 | $164 |
| Zimmer Biomet | 2 | $134 |
| Skeletal Dynamics Inc | 1 | $75 |
| Bioventus LLC | 4 | $74 |
| C. R. Bard, Inc. & Subsidiaries | 2 | $51 |
| Miach Orthopaedics, Inc. | 1 | $41 |
| Innovation Technologies Inc | 1 | $40 |
| AstraZeneca | 1 | $23 |
| Catalyst Orthoscience | 1 | $21 |
| Radius Health, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$28,267 in reported general payments places this provider in the 80th percentile of 381 orthopaedic surgery providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 49 | $805 |
| Ondansetron OdtOndansetron | 14 | $89 |
| Meloxicam | 11 | $35 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Gallatin
- Paul BradyKnoxville$20M
- Edwin SpencerKnoxville$2.5M
- Jesse DotyChattanooga$2.3M
- Thomas ThrockmortonGermantown$1.7M
- Alton HunterColumbia$820K
- Jefferson MorrisonNashville$678K
- Michael BeebeMemphis$626K
- Gregory PolkowskiNashville$526K
- Matthew WillisNashville$498K
- Michael ChristieNashville$474K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.